DEA Publishes Long-Awaited Proposed and Final Rules for Telemedicine Prescribing

Lexology January 22, 2025
Hall Render Killian Heath & Lyman PC

This past week, the Drug Enforcement Administration (“DEA”) and the U.S. Department of Health and Human Services (“HHS,” and together with the DEA, the “Agencies”) announced the release of three highly anticipated rules related to the prescription of controlled substances through telemedicine. These new rules include:

• A final rule on the “Expansion of Buprenorphine Treatment via Telemedicine Encounter,” which allows practitioners to prescribe up to a six-month supply of buprenorphine via an audio-only telemedicine interaction;
• A proposed rule to establish “Special Registrations for Telemedicine and Limited State Telemedicine Registrations”; and
• A proposed rule promoting “Continuity of Care via Telemedicine for Veterans Affairs Patients.”

By way of background, the Agencies originally issued proposed rules relating to the remote prescription...

Today's Sponsors

Today's Sponsor